Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ESBL”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Not applicableEnrolling By InvitationNCT07818109
What this trial is testing

One Health Determinants of Rectal Colonization by ESBL-Producing Enterobacterales in the Community

Who this might be right for
Antimicrobial Resistance (AMR)ESBLGut Microbiota Dysbiosis+4 more
Hospital Italiano de Buenos Aires 432
Not applicableStudy completedNCT05413772
What this trial is testing

Temocillin in ESBL-Enterobacteriaceae Infections

Who this might be right for
Infectious Disease
Assistance Publique - Hôpitaux de Paris 29
Large-scale testing (Phase 3)Study completedNCT03543436
What this trial is testing

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Assistance Publique - Hôpitaux de Paris 29
Not applicableStudy completedNCT00167986
What this trial is testing

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Who this might be right for
Escherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 480
Not applicableStudy completedNCT04085380
What this trial is testing

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE)

Who this might be right for
Risk Factor
Assistance Publique - Hôpitaux de Paris 2,396
Not applicableStudy completedNCT00363220
What this trial is testing

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

Who this might be right for
InfectionE Coli InfectionsKlebsiella Infections+1 more
University of Pittsburgh 100
Large-scale testing (Phase 3)Looking for participantsNCT06050148
What this trial is testing

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Who this might be right for
Recurrent Urinary Tract Infection
Helsinki University Central Hospital 100
Post-approval studies (Phase 4)WithdrawnNCT01543347
What this trial is testing

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Who this might be right for
Urinary Tract Infection
Belpharma s.a.
Not applicableStudy completedNCT01838213
What this trial is testing

Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients

Who this might be right for
Urinary Tract InfectionInfection Due to ESBL BacteriaEnvironmental Contamination of ESBL
Vestre Viken Hospital Trust 760
Post-approval studies (Phase 4)Study completedNCT00488813
What this trial is testing

Study of Antibiotic Utilization Measures and Control of ESBLs in China

Who this might be right for
ICU Patient
Wyeth is now a wholly owned subsidiary of Pfizer 300
Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Large-scale testing (Phase 3)Study completedNCT03477422
What this trial is testing

CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria

Who this might be right for
Urinary Tract Infection ComplicatedAcute Pyelonephritis
Venus Remedies Limited 230
Post-approval studies (Phase 4)Study completedNCT00826670
What this trial is testing

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Who this might be right for
Enterobacteriaceae Infections
University Hospital, Geneva 58
Not applicableUnknownNCT02456818
What this trial is testing

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

Who this might be right for
Oncology [See Also, Affected System]Hematological DiseaseInfection Due to ESBL Escherichia Coli
University of Cologne 2,264
Not applicableStudy completedNCT04671290
What this trial is testing

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

Who this might be right for
Urinary Tract Infection Bacterial
Centre Hospitalier Annecy Genevois 144
Not applicableUnknownNCT06305455
What this trial is testing

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Who this might be right for
Antimicrobial Resistance
José Raimundo Araujo de Azevedo 200
Not applicableLooking for participantsNCT07345923
What this trial is testing

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

Who this might be right for
Infections, Enterobacteriaceae
University Hospital, Strasbourg, France 1,000
Not applicableStudy completedNCT03401242
What this trial is testing

Prevalence of ESBL and CPE in French Nursing Homes

Who this might be right for
Enterobacteriaceae Infections
Nantes University Hospital 734
Not applicableStudy completedNCT01612182
What this trial is testing

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Who this might be right for
End-stage Renal Disease
Inje University 1,289
Next Page